Jenburkt Pharmaceuticals standalone net profit rises 20.56% in the December 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 20.56% to Rs 6.51 crore in the quarter ended December 2024 as against Rs 5.40 crore during the previous quarter ended December 2023. Sales rose 3.45% to Rs 36.89 crore in the quarter ended December 2024 as against Rs 35.66 crore during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	36.89	35.66	3
OPM %	23.94	20.16	-
PBDT	10.30	8.47	22
PBT	9.52	7.84	21
NP	6.51	5.40	21